Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor

Published:2019-06-18 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Pagnini Cristiano,Pizarro Theresa T.,Cominelli Fabio

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference83 articles.

1. Inflammatory bowel disease;Abraham;N. Engl. J. Med.,2009

2. One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study;Amiot;Aliment. Pharmacol. Ther.,2017

3. Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases;Ananthakrishnan;Cell Host Microbe,2017

4. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis;Arijs;Gut,2009

5. Predictive value of epithelial gene expression profiles for response to infliximab in Crohn’s disease;Arijs;Inflamm. Bowel Dis.,2010

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects;Journal of Clinical Medicine;2024-07-08

2. Myeloid-derived growth factor ameliorates dextran sodium sulfate-induced colitis by regulating macrophage polarization;Journal of Molecular Medicine;2024-05-02

3. Recent advances in nanocarrier systems for ulcerative colitis: A new era of targeted therapy and biomarker integration;Journal of Drug Delivery Science and Technology;2024-03

4. A Versatile Intestine‐on‐Chip System for Deciphering the Immunopathogenesis of Inflammatory Bowel Disease;Advanced Healthcare Materials;2024-02-11

5. Blimp-1 and c-Maf regulate common and unique gene networks to protect against distinct pathways of pathobiont-induced colitis;2023-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3